ArticleBlood advances2026

Zamtocabtagene autoleucel in relapsed/refractory B-NHL: 5-year follow-up of a CD20/19 tandem CAR T-cell phase 1 trial.

Hyatt Balke-Want et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.